Explore Our Cancer Journals Collection

Cancer Journals Collection

CANCER JOURNALS COLLECTION

The IOS Press Cancer Journals Collection features a portfolio of five international, rigorously peer-reviewed journals that promote translational medicine. They are dedicated to advancing research, identifying preventive methods, improving diagnosis and treatment, and working towards improving patient outcomes. The journals are committed to the highest ethical standards and best practices.

 

Journals are currently Gold Open Access or will transition as of January 2024.
 

 Key OA and Online Only

publish
We invite you to browse content and submit to IOS Press journals in cancer research and clinical oncology. Check the journal entries below to link to content, instructions for authors and manuscript submission guidelines.

CANCER JOURNALS COLLECTION

Discover more about each journal in this collection.

BLC journal coverBladder Cancer

open_access

bladdercancerjournal.com
iospress.com/bladder-cancer

 

 

Bladder Cancer is the official journal of the Bladder Cancer Advocacy Network and partners with Grand Rounds in Urology
 

KCAN image transparant

 

 

 

 

  

The only journal devoted exclusively to bladder cancer 

The official journal of the Bladder Cancer Advocacy Network, Bladder Cancer is an international multidisciplinary journal that facilitates progress in understanding the epidemiology, etiology, molecular genetics, pathogenesis, pathobiology and pharmacology of tumors of the bladder and upper urinary tract with the objective of improving diagnosis, treatment and survivorship in patients. The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. 

The Editors-in-Chief and Associate Editors are key opinion leaders who rigorously oversee many aspects of the article submission process including peer review and acceptance decisions in their respective areas of expertise.

Special Editorial Features
•    Challenging Cases section with active community engagement on clinical approaches, managed by an Associate Editor
•    Clinical Trials Corner
•    Paper Alert section highlighting publications from numerous sources of interest to the bladder cancer community,
     overseen by an Associate Editor
•    Systematic Reviews curated by a team of Associate Editors 
•    Guest Blogs, welcoming submissions, subject to Editorial approval 

Editors-in-Chief
Seth P. Lerner, MD, Baylor College of Medicine
Dan Theodorescu, MD, PhD, Cedars-Sinai Medical Center, Los Angeles

Seth P. Lerner, MD, received the 2023 American Urological Association’s Presidential Citation for dedication to clinical trials and studying the genetic foundations of bladder cancer and is the 2023 chair of the SWOG Cancer Research Network’s genitourinary research committee.

Indexing includes Web of Science, Scopus, PubMed Central (selective coverage), Directory of Open Access Journals (DOAJ)

KCA CoverBreast Disease

An International Journal

open_access

iospress.com/breast-disease

 

 

Now in its 46th volume, a timely and important resource serving the information needs of scientists, clinicians, and policy makers

Breast Disease is an international peer-reviewed journal publishing papers on topics such as basic cellular and molecular biology, epidemiology, genetics, clinical research, imaging, and social and legal issues. The journal promotes cross-disciplinary scientific discovery and understanding the public implications of these advancements.

Editorial Features
•    Ongoing publication in one continuous issue/volume per year
•    Case Reports
•    Research Advancements
•    Systematic Reviews

Founding Editor
Edison T. Liu, MD, President and CEO of The Jackson Laboratory

CiteScore: 1.3**
Indexing includes Scopus, PubMed/MEDLINE, Chemical Abstracts

Cancer BiomarkersCancer Biomarkers
open_access

iospress.com/cancer-biomarkers

 

 

 

 

Launched in 2005, among the most highly regarded journals concentrating on molecular biomarkers in cancer research

Cancer Biomarkers publishes content on the identification of markers associated with the prevention, detection, diagnosis, and treatment of cancer whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomic, cellular and morphologic, and genetic risk factors predisposing to the disease or indicating the occurrence of the disease. Data science, artificial intelligence, radiomics, and other molecular approaches, such as bulk and single cell genomic sequence analyses for biomarkers discovery, development, and validation in reference to cancer prevention and treatment, are accepted.

Special Editorial Features
•    Important new findings focusing on molecular screening and early detection
•    Introduction of innovative methodologies integrating new technologies such as AI
•    Special Themed Issues including Applications of Artificial Intelligence in Biomarker Research 

Editor-in-Chief
Sudhir Srivastava, PhD, MPH

Sudhir Srivastava, PhD, MPH, was awarded the 2022 Don Listwin Award for Outstanding Contribution to Cancer Early Detection.

Impact Factor: 3.1*
CiteScore: 6.1**
Indexing includes Web of Science, Scopus, PubMed/MEDLINE

KCAKidney Cancer

open_access
journalkidneycancer.com
iospress.com/kidney-cancer

 

 

 
Kidney Cancer partners with the Kidney Cancer Association and Grand Rounds in Urology 

KCAN image transparant

 

 

 

  

 

Since its launch in 2017, Kidney Cancer has been going from strength to strength 

Kidney Cancer is an international multidisciplinary journal facilitating progress in understanding the epidemiology, etiology, genetics, molecular correlates, pathogenesis, pathobiology, and pharmacology of tumors of the kidney with the objective of improving diagnosis, treatment, and survivorship in patients. The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. 

The Editors-in-Chief and Associate Editors are key opinion leaders who rigorously oversee many aspects of the article submission process including peer review and acceptance decisions in their respective areas of expertise.

Special Editorial Features
•    Ongoing publication in one continuous issue/volume per year
•    Clinical Trials Corner
•    Special Themed Issues (forthcoming in 2024: Kidney Cancer Pathology)
•    Systematic Reviews curated by a team of Associate Editors 

Editors-in-Chief
Primo N. Lara, Jr., MD, University of California Davis
Peter Mulders, MD, PhD, Radboud UMC (Nijmegen)

Indexing includes Web of Science, Scopus, PubMed Central (selective coverage), Directory of Open Access Journals (DOAJ)

TUB blue journal coverTumor Biology

open_access
iospress.com/tumor-biology

 

 

 

KCAN image transparant

 

 

  

The Official Journal of the International Society of Oncology and BioMarkers (ISOBM), published by IOS Press since 2021 

Tumor Biology is a peer-reviewed, international journal providing an open access forum for experimental and clinical cancer research. It covers all aspects of tumor markers, molecular biomarkers, tumor targeting, and mechanisms of tumor development and progression. Studies in other areas of basic, clinical, and translational cancer research are also considered in order to promote connections and discoveries across different disciplines.

Special Editorial Features
•    Conference Abstracts
•    Important new findings for the scientific exploration and clinical implementation of new biomarkers
•    Special Themed Issues including Lung Cancer Tumor Markers (forthcoming)

Editor-in-Chief
Magdalena Chechlinska, PhD, Dr Habil, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw

CiteScore: 5.4**
Indexing includes Scopus, PubMed/MEDLINE, Directory of Open Access Journals (DOAJ)

*Journal Citation Reports (Source Clarivate, 2023)
**Scopus, 2023

Publish with Us

  • Peer Review

    All our publications adhere to stringent peer review practices.

  • Ethics Policy

    Read our general publication ethics guidelines before submission.

  • Open Access

    Options are available to publish open access in all our journals.

  • Article Sharing Policy

    Information about the sharing options for articles.

  • Institutional Deals

    Check out the open access agreements per country.

  • Sustainable Development Goals

    All 5 cancer journals support the United Nation’s SDG Publishers Compact.